Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.
(From left) Sharliza, See and MAB Engineering Services chief of independent monitoring function and safety management Nurul Ain Afiqah Sallehuddin with the creations of Srap2Fab. It is often easy to ...
The research highlights how NAV-005 overcomes the immunosuppressive effects that tumor-produced CA125 has on antibodies ...
July 15, 2026) - Frost & Sullivan has officially released the "Global Antibody Drug Industry Development Blue Book 2026". The Blue Book provides a systematic overview of the current landscape and ...
Therapeutic antibodies selectively eliminated existing stem cells in mice while sparing gene-edited donor cells, offering a ...
Why SMEs must regularly re-examine cyber measuresIt is much easier for hackers to target hundreds of smaller businesses with ...
TrueLab Biopharmaceutical Announces License Agreement with Bionyra Pharma for Two Next-Generation Monoclonal and Bispecific Antibodies for Immune-Mediated Inflammatory Diseases Valued up to $985 ...
Researchers at Mount Sinai have developed the first fully human monoclonal antibody cocktail to provide complete protection against Nipah and Hendra viruses in preclinical models, offering a potential ...
From 647 applications worldwide, Hummingbird Bioscience was selected by an independent judging panel as a winner at the AI Discovery Awards ...
Interesting Engineering on MSN
New air-powered battery includes built-in self-destruct for sensitive devices
Researchers at Rice University and North Carolina State University have developed a stretchable battery ...
LightPath Technologies, Inc. ("LightPath," the "Company," "we," or "our"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results